Naveen Karkada
Rixensart, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Adopting the estimand framework in prophylactic vaccine trials.
Journal: Vaccine
Published: July 11, 2025
Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials.
Journal: Pharmaceutical statistics
Published: August 23, 2023
Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies.
Journal: Pharmaceutical statistics
Published: May 03, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up study.
Journal: Asia-Pacific journal of clinical oncology
Published: July 23, 2021
Inference under covariate-adaptive randomization: A simulation study.
Journal: Statistical methods in medical research
Published: January 28, 2021
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.
Journal: Human vaccines & immunotherapeutics
Published: November 12, 2020
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.
Journal: The Journal of infectious diseases
Published: May 18, 2020
Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children.
Journal: Infectious diseases and therapy
Published: May 14, 2020
Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study.
Journal: Asia-Pacific journal of clinical oncology
Published: September 12, 2019
Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
Journal: The Pediatric infectious disease journal
Published: August 31, 2019
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.
Journal: EClinicalMedicine
Published: August 28, 2019
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.
Journal: Human vaccines & immunotherapeutics
Published: July 04, 2019
Last Updated: 09/26/2026